{"name":"IPCA Laboratories Ltd.","slug":"ipca-laboratories-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Quetiapine Fumarate Tablets 25 mg","genericName":"Quetiapine Fumarate Tablets 25 mg","slug":"quetiapine-fumarate-tablets-25-mg","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Quetiapine Fumarate Tablets 25 mg","genericName":"Quetiapine Fumarate Tablets 25 mg","slug":"quetiapine-fumarate-tablets-25-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxNWUpvZzE5WjlPMGVJYWctdlRvdHQ1UlA4VzM1YjJ5QVRUaXdWOGswcGM5WE9oanZVTV80VkJFMmQ1WkY0ZWdFeEE5cGNlVXhYcFFEcGxCQi15VkxvMlcyTDBuOHgyZkd6WlJiV0ZhTURCWjFVc3NXNzE0Sm1GZFpKbUZsTThVTHNyY0hrdlhRS1RaZG5JMG5HX3I0VXg3c1FuVzJkVzFOZUJjR0JlVlROdnJrTng2bzkxbXlUTFVUWFVsZEtZRndieFJ3?oc=5","date":"2026-04-07","type":"pipeline","source":"Markets Mojo","summary":"Ipca Laboratories Ltd Valuation Shifts to Fair Amidst Sector Comparisons - Markets Mojo","headline":"Ipca Laboratories Ltd Valuation Shifts to Fair Amidst Sector Comparisons","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxNc1lkMy13VjFKdGJiTnRwQWl0VER5V012dUZYV3lDRU9hbERoUm5TR1BYRDVXTjJxNWJhZkE3aGVQcGdNV3Q1Y2tYa2dWR1g0MXNabFFTd21CTzZxbnRiMk53b3dZOXFhTmRmVEdRbkRFakp1cVotYkhjZTU0QVBzSndWR3JzUkdXZGJpOHgwbFg2X0NzSGZEQkd3dkFvcHdIWlM2cHhPaVk1WXVMN3VCMEpEeTdLU2F2dnpQZjg2N2NPc3d2T1lKQUNhd0hIcWpaN0RkU21Wcw?oc=5","date":"2026-04-02","type":"pipeline","source":"Markets Mojo","summary":"Ipca Laboratories Ltd Downgraded to Hold Amid Valuation and Technical Concerns - Markets Mojo","headline":"Ipca Laboratories Ltd Downgraded to Hold Amid Valuation and Technical Concerns","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-27","type":"pipeline","source":"Business Standard","summary":"Ipca Laboratories Ltd soars 1.62%, Gains for third straight session - Business Standard","headline":"Ipca Laboratories Ltd soars 1.62%, Gains for third straight session","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNYW53ZGc3ZzV6U1M3QVZDclVtNzN2eUlTTk9aTDlSNkZncGUtdkFHMHJRRHRBRUtaSHZTWjFqOHFncEVlb3hrdURUWFVuOGJhRElteWQ0R3A1cGplZkM0NTVDNXhEQkxObGZTU3k0MjZPSlVVV3hBaXY4ck81Z1VIY1JFTUZSaF9sd2QyUkpDbnBlc1FSM2ZHelBXRmZSQWJvc2VLX2tHVjJmc2pxSFVONTdKSnJuekFBUHpId09XclRxRjZXRHM4?oc=5","date":"2026-03-21","type":"earnings","source":"AD HOC NEWS","summary":"Ipca Laboratories Ltd stock hits new 52-week high amid strong earnings and analyst upgrades - AD HOC NEWS","headline":"Ipca Laboratories Ltd stock hits new 52-week high amid strong earnings and analyst upgrades","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPQjBVVkNzSjdqRXdTU3J4TE12Q1B1am4tbzhGQlpnaV80MjlYTEVhb0VTZEpQcGk2WGF1bGU1RUhPLWh0SDFkTWlNSHRtaGxzeEpRbWt0TE5lX0dyR3NYZmF5MjFYU0tBSkxWVFZBTU1CLU5IUEplMFUzYVFHQ08xSDFEODBUampIeHhXSU90N3dWNnU4OXl0SDZudTQwWlRtYW1tY0VMRllkSGIwblJLQlQtTFZPYncxbWhQMw?oc=5","date":"2026-03-13","type":"deal","source":"AD HOC NEWS","summary":"Ipca Laboratories Ltd Stock (ISIN: INE571A01038) Upgraded to Buy Amid Bullish Momentum and Strong Fi - AD HOC NEWS","headline":"Ipca Laboratories Ltd Stock (ISIN: INE571A01038) Upgraded to Buy Amid Bullish Momentum and Strong Fi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPMWkwMFM0NDlxWTZkVlZBb1l0d1lleGNmNGtCVENEeWVWdmt5WXh5OTZiTVlGNEQxb0Qwc3VUNGhwaEdJa1pqdFp4anE5RmNpTGJBWkdwdkZKdkpTcDk5ZEoySDVuMEhibEkxajVWemsyb1FMSHY2MDF1bXdicENuZFdJLUlURXJmSU1GMWdCY19xdktrY0c5dGJDTHE1X0I0Yno0WUo1MjAtM2MzdUpiY3FzaDk2QXIzTTJlZlUtUF9lUGtJMDB2VTY4Y1JoUQ?oc=5","date":"2026-02-27","type":"pipeline","source":"Samco","summary":"Ipca Laboratories Ltd Shows Follow-Through Potential Amid Broad-Based Pharma Strength - Samco","headline":"Ipca Laboratories Ltd Shows Follow-Through Potential Amid Broad-Based Pharma Strength","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxOMUJBRjF0YXE3ajl0OUFKdjVYMTJ3Z0RYNkJqeWlxaU4yNWFIR3JYdXhUUTRVVUs4RmJ5b1RDRFduNnRCUFgwOEt6UXJLbXo3MnAwOHJqZnptUmtoR2h2ZnptcnFicUFBRG5BRTA3S2R6dUJXMWlzSC1jYkZHQTA3X2daaXdXQ1BxSDhBZ1dSZE1EZXlXVkVvcjMxRWt3QmUyODdHSGcxdGdMOEdXdmZ2ODQ4YkhwdWhuaEt3VERfNndlQWhjaFB1SHFVYkEzZEE?oc=5","date":"2026-01-12","type":"pipeline","source":"scanx.trade","summary":"Ipca Laboratories Sells US Subsidiary Bayshore Pharmaceuticals for $400,000 - scanx.trade","headline":"Ipca Laboratories Sells US Subsidiary Bayshore Pharmaceuticals for $400,000","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNQXJHUm1TaWp4MkNBQl9iZGlSN2M0WUVNV3Izc1hESXRjNFg3azlJbGwzNlNKU2l1a1NkdURUVHBJTW9Zd3FnYy1SUEdEY2YzSUZ5Mi1La3o0NVB4MVpJc0tRZ0U0SGtPeW8yQ1pMdU1WRTlsc0NMdDFQa0dYX0lRQldNOWpHZlQwS25ybXBYckk3c0xIS2xrZ2lyeEVJdi1faGxNdmd2d1Vwd2N0WUtDdXprdTZxdXhuM3NZRHNJQUVQbUxWVTJ3WnZoallJanBqTWc?oc=5","date":"2026-01-12","type":"pipeline","source":"scanx.trade","summary":"IPCA Laboratories Divests US Subsidiary Bayshore Pharmaceuticals for $400,000 - scanx.trade","headline":"IPCA Laboratories Divests US Subsidiary Bayshore Pharmaceuticals for $400,000","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-08","type":"pipeline","source":"Business Standard","summary":"Ipca Laboratories Ltd spurts 2.08%, rises for fifth straight session - Business Standard","headline":"Ipca Laboratories Ltd spurts 2.08%, rises for fifth straight session","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-12","type":"pipeline","source":"The Economic Times","summary":"Stock Radar: 20% fall from highs! This pharma stock is showing signs of bottoming out - The Economic Times","headline":"Stock Radar: 20% fall from highs! This pharma stock is showing signs of bottoming out","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-25","type":"earnings","source":"NDTV Profit","summary":"Deals, Drugs, And Disruption: Glenmark, Lupin, IPCA Labs And Others Lead India's Pharma Opportunity Boom - NDTV Profit","headline":"Deals, Drugs, And Disruption: Glenmark, Lupin, IPCA Labs And Others Lead India's Pharma Opportunity Boom","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPRWJoMVZxTkQ3bXhmQlJHWGhiWE5Ebk1fUDFoSFZ2dzZrWHczUzhRdW5fUzRjUzVmYnptNmVMUzJiWkJYZW5FT3J1MHV2U3BpTkxwbGxaNVpueDhITjhvRFVHaWpORmZfem1NNjBjZURIWXB5Wm1IUTE2UnNyYlhScVkwel9LNHpySlZHbjMxdWM3R2R0Z2MwdmxPcUlGTzQyOW15WVBZT3o5a0ZiYnhWVy1ua00zMk1tMG1B0gHAAUFVX3lxTE55MlRuT0I4ckRiZ1JwVEFrYUNEbEY2dU1fa0tFQlRyTzhsQTFSYlc3Vk9tMEtSdzdjYTNDV0Q1cUU1bjgxU2RVbHBTWFNkYkJwb0NIMng4LTJ2TVhLR2xKTFBoWkM3NWk5d3hHbi0wU190QU4xUG94WmtvVXNkcExjeFBUejB1VG9oRWFLOTU5RmMxNk9hRnl3R2EyTXNfUldmWHlHQi1SX3NmdGlJbDdsTnJ6YWpIU1VJV25Md04wVA?oc=5","date":"2025-06-16","type":"pipeline","source":"medicaldialogues.in","summary":"Ipca Labs appoints Dr Nagaji Ambabhai Vekariya as President - CRD - medicaldialogues.in","headline":"Ipca Labs appoints Dr Nagaji Ambabhai Vekariya as President - CRD","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}